JP2010517990A5 - - Google Patents

Download PDF

Info

Publication number
JP2010517990A5
JP2010517990A5 JP2009547778A JP2009547778A JP2010517990A5 JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5 JP 2009547778 A JP2009547778 A JP 2009547778A JP 2009547778 A JP2009547778 A JP 2009547778A JP 2010517990 A5 JP2010517990 A5 JP 2010517990A5
Authority
JP
Japan
Prior art keywords
condition
composition
compound
composition according
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009547778A
Other languages
English (en)
Japanese (ja)
Other versions
JP4599462B2 (ja
JP2010517990A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/000229 external-priority patent/WO2008093227A1/en
Publication of JP2010517990A publication Critical patent/JP2010517990A/ja
Publication of JP2010517990A5 publication Critical patent/JP2010517990A5/ja
Application granted granted Critical
Publication of JP4599462B2 publication Critical patent/JP4599462B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009547778A 2007-02-02 2008-01-25 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用 Expired - Fee Related JP4599462B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88798107P 2007-02-02 2007-02-02
PCT/IB2008/000229 WO2008093227A1 (en) 2007-02-02 2008-01-25 Tricyclic compounds and their use as glucocorticoid receptor modulators

Publications (3)

Publication Number Publication Date
JP2010517990A JP2010517990A (ja) 2010-05-27
JP2010517990A5 true JP2010517990A5 (cg-RX-API-DMAC7.html) 2010-08-12
JP4599462B2 JP4599462B2 (ja) 2010-12-15

Family

ID=39315208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009547778A Expired - Fee Related JP4599462B2 (ja) 2007-02-02 2008-01-25 三環式化合物およびそれらのグルココルチコイド受容体調節剤としての使用

Country Status (42)

Country Link
US (7) US7598231B2 (cg-RX-API-DMAC7.html)
EP (1) EP2114970B1 (cg-RX-API-DMAC7.html)
JP (1) JP4599462B2 (cg-RX-API-DMAC7.html)
KR (2) KR101107949B1 (cg-RX-API-DMAC7.html)
CN (2) CN101616925B (cg-RX-API-DMAC7.html)
AP (1) AP2455A (cg-RX-API-DMAC7.html)
AR (2) AR065134A1 (cg-RX-API-DMAC7.html)
AT (1) ATE518872T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008211613B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0808634A2 (cg-RX-API-DMAC7.html)
CA (1) CA2676670C (cg-RX-API-DMAC7.html)
CL (2) CL2008000329A1 (cg-RX-API-DMAC7.html)
CO (2) CO6220937A2 (cg-RX-API-DMAC7.html)
CR (2) CR10949A (cg-RX-API-DMAC7.html)
CU (2) CU23848B1 (cg-RX-API-DMAC7.html)
CY (2) CY1110962T1 (cg-RX-API-DMAC7.html)
DK (1) DK2114970T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2009000190A (cg-RX-API-DMAC7.html)
EA (1) EA016494B1 (cg-RX-API-DMAC7.html)
EC (2) ECSP099552A (cg-RX-API-DMAC7.html)
ES (2) ES2368286T3 (cg-RX-API-DMAC7.html)
GE (2) GEP20125404B (cg-RX-API-DMAC7.html)
GT (2) GT200900209A (cg-RX-API-DMAC7.html)
HN (2) HN2008000179A (cg-RX-API-DMAC7.html)
HR (1) HRP20110702T1 (cg-RX-API-DMAC7.html)
IL (1) IL199972A (cg-RX-API-DMAC7.html)
MA (2) MA31158B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009008284A (cg-RX-API-DMAC7.html)
MY (3) MY153057A (cg-RX-API-DMAC7.html)
NI (2) NI200900148A (cg-RX-API-DMAC7.html)
NZ (1) NZ578638A (cg-RX-API-DMAC7.html)
PE (2) PE20081736A1 (cg-RX-API-DMAC7.html)
PL (1) PL2114970T3 (cg-RX-API-DMAC7.html)
PT (2) PT2114970E (cg-RX-API-DMAC7.html)
RS (2) RS51970B (cg-RX-API-DMAC7.html)
SI (1) SI2114970T1 (cg-RX-API-DMAC7.html)
SV (2) SV2009003346A (cg-RX-API-DMAC7.html)
TN (1) TN2009000324A1 (cg-RX-API-DMAC7.html)
TW (2) TWI347842B (cg-RX-API-DMAC7.html)
UA (2) UA94639C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008093227A1 (cg-RX-API-DMAC7.html)
ZA (2) ZA200906060B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
PT2114970E (pt) 2007-02-02 2011-09-22 Pfizer Prod Inc Compostos tricíclicos e sua utilização como moduladores de receptor de glucocorticóide
KR101377860B1 (ko) * 2008-07-28 2014-03-25 화이자 인코포레이티드 페난트렌온 화합물, 조성물 및 방법
US8765787B2 (en) * 2008-11-21 2014-07-01 Bridge Pharma, Inc. Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137843A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Delivery devices for modulating inflammation
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
AU2011251622A1 (en) 2010-05-10 2012-12-20 Radikal Therapeutics Inc. Lipoic acid and nitroxide derivatives and uses thereof
BR112013004322A2 (pt) * 2010-08-27 2016-06-21 Corcept Therapeutics Inc moduladores de azadecalin fundidos com piridil-aminas
UY33957A (es) * 2011-03-15 2012-10-31 Abbott Lab Moduladores de los receptores de hormonas nucleares
US8545904B1 (en) 2012-06-05 2013-10-01 Liquid Innovators, LLC Topical composition containing Carapa (andiroba) oil for psoriasis and other related dermatological disorders
US9227901B2 (en) 2012-07-05 2016-01-05 Abbvie Inc. Process for preparing bicyclic amine derivatives
TW201422590A (zh) 2012-09-07 2014-06-16 Abbvie Inc 雜環核激素受體調節劑
EP2935284A4 (en) 2012-12-21 2016-04-27 Abbvie Inc HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS
AU2015258904A1 (en) 2014-05-16 2016-11-17 Liqwd, Inc. Keratin treatment formulations and methods
KR102601505B1 (ko) * 2014-10-20 2023-11-14 오이스터 포인트 파마 인코포레이티드 안과 질환의 치료 방법
CN104591988A (zh) * 2014-12-29 2015-05-06 甘肃省化工研究院 6-溴-2-萘满酮的合成方法
CN113350353A (zh) * 2015-03-23 2021-09-07 墨尔本大学 呼吸性疾病的治疗
ES2893126T3 (es) 2016-04-07 2022-02-08 Oyster Point Pharma Inc Métodos de tratamiento de afecciones oculares
EP3877383A4 (en) 2018-11-07 2022-09-21 The University of Melbourne COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY DISEASES

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576025B1 (fr) 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
FR2600450B1 (fr) * 1986-06-19 1988-08-26 Pechiney Aluminium Procede de marquage individuel des anodes precuites pour la production electrolytique d'aluminium
GB9518953D0 (en) * 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
IL122740A (en) 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
EE05584B1 (et) * 1999-04-30 2012-10-15 Pfizer Products Inc. Glkokortikoidretseptori modulaatorid
US6544781B1 (en) 1999-07-15 2003-04-08 The General Hospital Corporation Non-defective Epstein-Barr viral vector
IL146057A (en) * 2000-10-27 2007-09-20 Pfizer Prod Inc A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
ES2262612T3 (es) * 2000-10-28 2006-12-01 Pfizer Products Inc. Moduladpres del receptor de glucocorticoides.
ES2246292T3 (es) * 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
KR100793464B1 (ko) * 2000-11-20 2008-01-14 시게이트 테크놀로지 엘엘씨 Rfid 태그 및 이를 디스크 드라이브에 부착하는 방법
MXPA03011935A (es) 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
MXPA04001893A (es) 2001-08-31 2005-03-07 Corcept Therapeutics Inc Metodos para inhibir deterioro cognoscitivo en adultos con sindrome de down.
EP1432684B1 (en) 2001-09-27 2009-03-25 Université de Liège Pyridinic sulfonamide derivatives, method of production and use thereof
DE10164366C1 (de) * 2001-12-28 2003-06-05 Rehau Ag & Co Permanentkathode
CA2474838C (en) 2002-02-01 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
CN1665515A (zh) 2002-07-02 2005-09-07 科塞普特治疗公司 治疗与干扰素α治疗相关的精神病的方法
CA2491994C (en) * 2002-07-08 2013-11-05 Pfizer Products Inc. Modulators of the glucocorticoid receptor
EP1581234A4 (en) 2002-11-05 2007-09-12 Corcept Therapeutics Inc METHODS FOR TREATING MIGRAINE
CA2514966A1 (en) 2003-02-04 2004-08-19 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of postpartum psychosis
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
US20050080061A1 (en) 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
TW200512181A (en) 2003-09-26 2005-04-01 Tanabe Seiyaku Co Amide-type carboxamide derivatives
ES2398239T3 (es) * 2003-11-10 2013-03-14 The Scripps Research Institute Composiciones y procedimientos para inducir la desdiferenciación celular
JP2007511501A (ja) * 2003-11-13 2007-05-10 ファイザー・プロダクツ・インク グルココルチコイド受容体調節剤として有用なオクタヒドロフェナンスレンヒドラジド誘導体
TWI370129B (en) 2005-02-14 2012-08-11 Msd Oss Bv Non steroidal glucocorticoid receptor modulators
WO2007131041A2 (en) 2006-05-02 2007-11-15 Corcept Therapeutics, Inc. The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
PT2114970E (pt) 2007-02-02 2011-09-22 Pfizer Prod Inc Compostos tricíclicos e sua utilização como moduladores de receptor de glucocorticóide
BRPI0807121A2 (pt) * 2007-02-02 2014-04-08 Pfizer Prod Inc Compostos tricíclicos e seu uso como moduladores de receptor glicocorticóide

Similar Documents

Publication Publication Date Title
JP2010517990A5 (cg-RX-API-DMAC7.html)
JP2010533203A5 (cg-RX-API-DMAC7.html)
CA2676670A1 (en) Tricyclic compounds, compositions, and methods
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2010517991A5 (cg-RX-API-DMAC7.html)
JP2007535611A5 (cg-RX-API-DMAC7.html)
JP2014029971A5 (ja) 有機化合物
JP2011513196A5 (cg-RX-API-DMAC7.html)
JP2013505929A5 (cg-RX-API-DMAC7.html)
JP2010534247A5 (cg-RX-API-DMAC7.html)
JP2010141309A5 (ja) 発光素子
JP2009149903A5 (cg-RX-API-DMAC7.html)
JP2007537295A5 (cg-RX-API-DMAC7.html)
JP2011500769A5 (cg-RX-API-DMAC7.html)
JP2010530897A5 (cg-RX-API-DMAC7.html)
JP2014514960A5 (cg-RX-API-DMAC7.html)
JP2010530373A5 (cg-RX-API-DMAC7.html)
JP2014515008A5 (cg-RX-API-DMAC7.html)
JP2010516852A5 (cg-RX-API-DMAC7.html)
CA2676907A1 (en) Tricyclic compounds and their use as glucocorticoid receptor modulators
JP2014097964A5 (cg-RX-API-DMAC7.html)
JP2014028784A5 (ja) 複素環化合物および有機化合物
JP2011519825A5 (cg-RX-API-DMAC7.html)
JP2011525899A5 (cg-RX-API-DMAC7.html)
JP2012094862A5 (cg-RX-API-DMAC7.html)